Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: LAW

COPAN Italia S.p.A. announces the filing of a lawsuit against Svenska Laboratorieförsäljningen Aktiebolag, LABFAB, in the Swedish Patent and Market Court, for infringement of European Patent EP 1 608 268 B2


BRESCIA, Italy, April 26, 2019 /PRNewswire/ -- COPAN is the global leader in preanalytical collection and transport devices serving the microbiology and medical communities. In the lawsuit, COPAN asserts that Svenska LABFAB has committed a willful infringement of the patent covering COPAN's core flocked swab technology, in connection with the distribution in Sweden of products manufactured by Medical Wire & Equipment Co. Ltd. and comprising flocked swabs made by Puritan. "The scientific community and market universally recognize COPAN's founder, Daniele Triva, as the inventor of flocked swabs for collecting biological specimens. That invention, in 2003, revolutionized the industry," said Lorenzo Fumagalli, COPAN's General Counsel. "Since then, COPAN has invested an enormous amount of time and resources to develop, manufacture, and patent these innovative solutions, as well as to convince an initially skeptical market to adopt them. COPAN cannot tolerate infringements of its intellectual property rights by certain manufacturers and distributors: this Swedish litigation, together with the ongoing one against Puritan in the USA, confirms COPAN's efforts in stopping the actions of those who we believe are violating our intellectual property rights."

About COPAN Group

With a reputation for innovation, the family-owned COPAN Group is the leading manufacturer of collection and transport systems in the world. COPAN's collaborative approach to innovation in pre-analytics has resulted in the original FLOQSwabstm, ESwabtm, FecalSwabtm and UTMtm, as well as Full Laboratory Automation. For more information, visit www.copangroup.com. 

 


These press releases may also interest you

at 19:20
Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") , a North American provider of cannabis products and services, announced executive management changes as outlined below. Kevin Wilkerson has been promoted to...

at 18:46
InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer's, CTE and other related Dementias. The award...

at 18:00
Our Mission Many children and adults with Attention Deficit Hyperactive Disorder (ADHD) have difficulties managing their symptoms. It can be very challenging for these individuals to succeed in school, in their careers and can have struggles with...

at 17:56
Rachel Shadley-Barlow's water broke at 14 weeks (Preterm Premature Rupture of Membranes or PPROM); doctors advised that nothing could be done to safely continue the pregnancy. Rachel and her husband Jesse decided to watch and wait, supported by an...

at 17:55
Today, addiction treatment search engine WeRecover announced the launch of the WeRecover app for both iOS and Android. WeRecover is a venture-backed technology company committed to  broadening access to care for addiction treatment. They have helped...

at 17:30
Ra Pharmaceuticals, Inc. ("Ra Pharma") today announced that it intends to offer and sell, subject to market and other conditions, $100 million of its common stock in an underwritten public offering. Ra Pharma expects to grant the underwriters a...



News published on 26 april 2019 at 01:29 and distributed by: